KRAS G12C Inhibition in Non-Small Cell Lung Cancer
KRAS G12C Inhibition in Non-Small Cell Lung Cancer
Dec 19, 2020
findkrasg12c.com
KRAS G12C in mNSCLC
KRAS G12C in mNSCLC
339 viewsJan 8, 2024
vumedi.com
Frontline Treatments for KRAS G12C-Mutation mNSCLC | OncLive
9:17
Frontline Treatments for KRAS G12C-Mutation mNSCLC | OncLive
Nov 30, 2023
onclive.com
The Current and Evolving Role of KRAS G12C and Pan-KRAS Inhibitors in Metastatic PDAC | OncLive
3:47
The Current and Evolving Role of KRAS G12C and Pan-KRAS Inhibit…
6 months ago
onclive.com
2L KRAS Inhibitors for Patients With KRAS G12C–Mutated NSCLC
2L KRAS Inhibitors for Patients With KRAS G12C–Mutated NSCLC
Dec 30, 2022
onclive.com
Treatment of KRAS G12C Mutant NSCLC
Treatment of KRAS G12C Mutant NSCLC
May 11, 2022
onclive.com
Overview of KRAS G12C Mutations in NSCLC | AJMC
Overview of KRAS G12C Mutations in NSCLC | AJMC
Jul 6, 2022
ajmc.com
What's Happening in KRAS G12C NSCLC?
Apr 9, 2021
onclive.com
1:09
18 reactions · 8 comments | Now live in Pulm Ex from Level Ex! Take th…
12.2K views1 month ago
FacebookAmgen
Therapeutic Options for mCRC with KRAS G12C Mutations
Apr 25, 2024
onclive.com
Adagrasib Demonstrates Superiority in KRAS G12C NSCLC | Targeted …
Oct 4, 2024
targetedonc.com
KRAS G12C Drugs and Utilizing Immune Oncology Approaches to …
97 views8 months ago
vumedi.com
Adagrasib for Patients with KRAS G12C–Mutant NSCLC | OncLive
2 weeks ago
onclive.com
2:11
Sotorasib is approved in the United States to treat KRAS p.G12C–mut…
2.6K viewsJan 4, 2023
FacebookThe New England Journal of Medicine
Dr Kopetz on Adagrasib Plus Cetuximab in KRAS G12C mCRC | …
Apr 19, 2024
onclive.com
Dr Gadgeel on Adagrasib Monotherapy in KRAS G12C–Muta…
2 weeks ago
onclive.com
Dr Skoulidis on the Methods of Analyzing KRAS G12C Inhibitor Ef…
May 23, 2023
onclive.com
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC | …
1 week ago
onclive.com
FDA Approves Sotorasib Plus Panitumumab for KRAS G12C–Mu…
2 weeks ago
onclive.com
Adagrasib Yields Durable Benefit for Patients With KRAS G12C–Mutant …
2 weeks ago
onclive.com
Dr. Patil on the Development of KRAS G12C Inhibitors in Lung Ca…
Sep 13, 2021
onclive.com
Dr Kopetz on the Background of the KRYSTAL-1 Trial in KRAS G12C m…
Apr 26, 2024
onclive.com
KRAS G12C–Mutated NSCLC: Real-World Implications of Novel Targe…
1 month ago
onclive.com
Dr Hong on Preliminary Activity With RMC-6291 in Advanced KRA…
Oct 18, 2023
onclive.com
Phase 1 Study Shows Potential of LY3537982 in KRAS G12C NSCLC …
Aug 6, 2023
targetedonc.com
Dr Kopetz on the Future Utility of Adagrasib/Cetuximab in KRAS G1…
Apr 30, 2024
onclive.com
Dr. Klempner on the Significance of KRYSTAL-1 Data in KRAS G12C–…
Nov 9, 2022
onclive.com
KRAS G12C Mutation An Emerging Biomarker for NSCLC
Jan 4, 2021
questdiagnostics.com
ESMO highlights: KRAS G12C inhibitors
700 viewsOct 20, 2022
YouTubeVJOncology
CodeBreak 100: assessing sotorasib in patients with KRAS p.G12C-mut…
380 viewsJun 7, 2022
YouTubeVJOncology
See more videos
Static thumbnail place holder